Biocept Inc (BIOCQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2019 | 12-2018 | |
| Sales | 25,858 | 61,249 | 27,461 | 5,529 | 3,250 |
| Cost of Goods | 28,440 | 37,764 | 21,337 | 10,978 | 10,052 |
| Gross Profit | -2,582 | 23,485 | 6,124 | -5,449 | -6,801 |
| Operating Expenses | 29,841 | 26,658 | 21,930 | 18,586 | 17,509 |
| Operating Income | -31,983 | -2,409 | -15,469 | -23,057 | -24,259 |
| Interest Expense | 316 | 290 | 236 | 250 | 311 |
| Other Income | 87 | 0 | -2,102 | -1,831 | 0 |
| Pre-tax Income | -32,212 | -2,699 | -17,807 | -25,138 | -24,570 |
| Income Tax | -125 | 125 | N/A | N/A | 2 |
| Net Income Continuous | -32,087 | -2,824 | -17,807 | -25,138 | -24,572 |
| Net Income | $-32,087 | $-2,824 | $-17,807 | $-25,138 | $-24,572 |
| EPS Basic Total Ops | -56.76 | -5.71 | -45.05 | -367.27 | -2,705.71 |
| EPS Basic Continuous Ops | -56.84 | -5.74 | -45.14 | -365.37 | -2,637.19 |
| EPS Diluted Total Ops | -56.76 | -5.71 | -45.05 | -367.27 | -2,705.71 |
| EPS Diluted Continuous Ops | -56.84 | -5.74 | -45.14 | -365.37 | -2,637.19 |
| EPS Diluted Before Non-Recurring Items | -56.76 | -5.71 | -45.05 | -366.37 | -2,705.71 |
| EBITDA(a) | $-30,328 | $-879 | $-14,468 | $-22,284 | $-23,458 |